MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/00031348261441680

Медицинская библиотека · The American surgeon · 2026

Mirizzi Syndrome: Optimal Timing and Management.

Molina Rogelio E, Rosenberg David M, Burrows Julia E, Kim Jane J, Petrovich Katherine A, Eade Alyssa V, Garcia Lorena, Keeley Jessica A

СтатьяПеревод в очереди

Аннотация

IntroductionMirizzi syndrome is uncommon with an incidence of 0.3% to 1.4% of all cholecystectomies and remains challenging given the potential need for biliary reconstruction. Standardized surgical guidelines are lacking, which continues to hinder the establishment of optimal operative strategies tailored to disease severity.ObjectiveEvaluate postoperative outcomes based on timing of diagnosis (preoperative vs intraoperative), timing of cholecystectomy (index vs delayed), and surgical subspecialty performing the operation.MethodsA multi-center retrospective review was conducted of all cholecystectomies performed between 2014 and 2023 across 3 Los Angeles County hospitals. Patients with Mirizzi syndrome were identified and stratified according to the Csendes classification. Primary outcomes included bile duct injury, bile leak, biloma, abscess, need for postoperative drainage or reoperation, and readmission. Comparisons were performed using Fisher's exact test.ResultsAmong 14 486 cholecystectomies performed during the study period, 65 patients (0.45%) met inclusion criteria. Complications were significantly lower in patients with preoperative diagnosis compared with intraoperative diagnosis, 25% vs 57% (P = 0.05). Most patients underwent index-admission cholecystectomy, 52/65 (80%). In advanced disease (types II-Va), complication rates did not differ between index and delayed surgery, 55% vs 38% (P = 0.67). Overall complication rates were similar between acute care surgery and hepatopancreatobiliary surgery, 24% vs 40% (P = 0.28). For type I disease, outcomes were comparable between services.ConclusionsPreoperative diagnosis of Mirizzi syndrome is associated with improved postoperative outcomes. Type I disease can be safely managed by either acute care or hepatopancreatobiliary surgeons, while delayed surgery in advanced cases appears safe to facilitate specialized care.

Для цитирования: Molina Rogelio E, Rosenberg David M, Burrows Julia E, Kim Jane J, Petrovich Katherine A, Eade Alyssa V, Garcia Lorena, Keeley Jessica A. Mirizzi Syndrome: Optimal Timing and Management.. The American surgeon. 2026. DOI: 10.1177/00031348261441680.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.